Ohio Medical Marijuana Control Program News - December 2019
OHIO MEDICAL MARIJUANA CONTROL PROGRAM PETITIONS TO ADD NEW QUALIFYING CONDITIONS - DEADLINE DECEMBER 31, 2019
As of today, Ohio’s medical marijuana program 21 qualifying conditions are “AIDS, amyotrophic lateral sclerosis, Alzheimer’s disease, cancer, chronic traumatic encephalopathy, Crohn’s disease, epilepsy or another seizure disorder, fibromyalgia, glaucoma, hepatitis C, inflammatory bowel disease, multiple sclerosis, pain that is either chronic and severe or intractable, Parkinson’s disease, positive status for HIV, post-traumatic stress disorder, sickle cell anemia, spinal cord disease or injury, Tourette’s syndrome, traumatic brain injury, and ulcerative colitis.”
However, RIGHT NOW and until December 31, Ohio is considering petitions to add new medical conditions to those already accepted in our state. Follow the link for more information. Please share this opportunity to shape state law and change patients’ lives with your doctor too.
https://www.medicalmarijuana.ohio.gov/condition
The Ohio Medical Marijuana Control Program (OMMCP) is operated by three different regulatory bodies: the Department of Commerce, the Pharmacy Board and the State Medical Board. The Department of Commerce oversees cultivators, processors and testing labs. The Pharmacy Board supervises dispensaries, patients/caregivers and products. The Medical Board certifies physicians and reviews qualifying conditions.
The next Ohio Medical Marijuana Control Program (OMMCP) Medical Marijuana Advisory Committee Meeting is scheduled for December 12, in Columbus, at the Rhodes Tower Lobby Hearing Room, beginning at 10 am. This committee of fourteen members represent multiple aspects of Ohio’s medical marijuana industry (pharmacists, doctors, patients, law enforcement, agriculture, caregivers, labor, employers, research, etc.) Prior to June 2019, they held their open meetings on a bi-monthly basis. Past agendas were posted the night before and included program reports and updates. Follow the link below for more information.